274 related articles for article (PubMed ID: 28476244)
1. Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors.
Alessandrino F; Tirumani SH; Krajewski KM; Shinagare AB; Jagannathan JP; Ramaiya NH; Di Salvo DN
Clin Radiol; 2017 Jul; 72(7):521-533. PubMed ID: 28476244
[TBL] [Abstract][Full Text] [Related]
2. The Liver in Oncology.
Dhanasekaran R; Kwo PY
Clin Liver Dis; 2017 Nov; 21(4):697-707. PubMed ID: 28987257
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.
Cramer P; Bresalier RS
Curr Gastroenterol Rep; 2017 Jan; 19(1):3. PubMed ID: 28124291
[TBL] [Abstract][Full Text] [Related]
4. Management of toxicities of immune checkpoint inhibitors.
Spain L; Diem S; Larkin J
Cancer Treat Rev; 2016 Mar; 44():51-60. PubMed ID: 26874776
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-Associated Hepatotoxicities.
White MA; Fong Y; Singh G
Surg Clin North Am; 2016 Apr; 96(2):207-17. PubMed ID: 27017860
[TBL] [Abstract][Full Text] [Related]
6. Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver.
Cleary JM; Tanabe KT; Lauwers GY; Zhu AX
Oncologist; 2009 Nov; 14(11):1095-105. PubMed ID: 19880627
[TBL] [Abstract][Full Text] [Related]
7. Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy.
Loriot Y; Perlemuter G; Malka D; Penault-Llorca F; Boige V; Deutsch E; Massard C; Armand JP; Soria JC
Nat Clin Pract Oncol; 2008 May; 5(5):268-78. PubMed ID: 18349858
[TBL] [Abstract][Full Text] [Related]
8. Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis of published data.
Wang W; Lie P; Guo M; He J
Int J Cancer; 2017 Sep; 141(5):1018-1028. PubMed ID: 28263392
[TBL] [Abstract][Full Text] [Related]
9. Identification and management of toxicities from immune checkpoint-blocking drugs.
Teply BA; Lipson EJ
Oncology (Williston Park); 2014 Nov; 28 Suppl 3():30-8. PubMed ID: 25384885
[TBL] [Abstract][Full Text] [Related]
10. Decade of molecular targeted therapy: abdominal manifestations of drug toxicities--what radiologists should know.
Howard SA; Krajewski KM; Thornton E; Jagannathan JP; O'Regan K; Cleary J; Ramaiya N
AJR Am J Roentgenol; 2012 Jul; 199(1):58-64. PubMed ID: 22733894
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury due to cancer chemotherapeutic agents.
Bahirwani R; Reddy KR
Semin Liver Dis; 2014 May; 34(2):162-71. PubMed ID: 24879981
[TBL] [Abstract][Full Text] [Related]
12. Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.
Alessandrino F; Krajewski KM; Tirumani SH; Braschi-Amirfarzan M; Jagannathan JP; Ramaiya NH; Di Salvo DN
Abdom Radiol (NY); 2017 Jun; 42(6):1721-1733. PubMed ID: 28160038
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms.
Fessas P; Possamai LA; Clark J; Daniels E; Gudd C; Mullish BH; Alexander JL; Pinato DJ
Immunology; 2020 Feb; 159(2):167-177. PubMed ID: 31646612
[TBL] [Abstract][Full Text] [Related]
14. [Management of Toxicities of Immune Checkpoint Inhibitors].
Horio Y
Gan To Kagaku Ryoho; 2017 Mar; 44(3):185-190. PubMed ID: 28292987
[TBL] [Abstract][Full Text] [Related]
15. Vascular toxicity associated with chemotherapy and molecular targeted therapy: what should a radiologist know?
Rohatgi S; Jagannathan JP; Rosenthal MH; Kim KW; Ramaiya NH; Krajewski KM
AJR Am J Roentgenol; 2014 Dec; 203(6):1353-62. PubMed ID: 25415715
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced hepatotoxicity.
Thatishetty AV; Agresti N; O'Brien CB
Clin Liver Dis; 2013 Nov; 17(4):671-86, ix-x. PubMed ID: 24099024
[TBL] [Abstract][Full Text] [Related]
17. Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation.
Keraliya AR; Rosenthal MH; Krajewski KM; Jagannathan JP; Shinagare AB; Tirumani SH; Ramaiya NH
AJR Am J Roentgenol; 2015 Oct; 205(4):709-19. PubMed ID: 26397319
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy induced liver abnormalities: an imaging perspective.
Sharma A; Houshyar R; Bhosale P; Choi JI; Gulati R; Lall C
Clin Mol Hepatol; 2014 Sep; 20(3):317-26. PubMed ID: 25320738
[TBL] [Abstract][Full Text] [Related]
19. Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
Zambelli A; Della Porta MG; Eleuteri E; De Giuli L; Catalano O; Tondini C; Riccardi A
Breast; 2011 Apr; 20(2):176-83. PubMed ID: 21146409
[TBL] [Abstract][Full Text] [Related]
20. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
